Adenosine: An endogenous mediator in the pathogenesis of gynecological cancer

NHERF1 Enhances Cisplatin Sensitivity in Human Cervical Cancer Cells

(2017) Tao Tao et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression

(2017) Wen-Ting Chen et al.   Journal of Ovarian Research

Ovarian cancer: density equalizing mapping of the global research architecture

(2017) Dörthe Brüggmann et al.   International Journal of Health Geographics

Immunosuppressive activities of adenosine in cancer

(2016) Bertrand Allard et al.   CURRENT OPINION IN PHARMACOLOGY

Mesenchymal stromal cells derived from cervical cancer produce high amounts of adenosine to suppress cytotoxic T lymphocyte functions

(2016) María de Lourdes Mora-García et al.   Journal of Translational Medicine

Less radical surgery for early-stage cervical cancer: To what extent do we justify it?—Our belief

(2016) Nikolaos Thomakos et al.   Taiwanese Journal of Obstetrics & Gynecology

CD73-adenosine reduces immune responses and survival in ovarian cancer patients

(2016) Pierre-Olivier Gaudreau et al.   OncoImmunology

Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages – a self-amplifying, CD39- and CD73-dependent mechanism for tumor immune escape

(2016) Itsaso Montalbán del Barrio et al.   Journal for ImmunoTherapy of Cancer

New insights in the pathophysiology of ovarian cancer and implications for screening and prevention

(2015) Farr R. Nezhat et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Activation of A2b adenosine receptor regulates ovarian cancer cell growth: involvement of Bax/Bcl-2 and caspase-3

(2015) Sima Hajiahmadi et al.   Biochemistry and Cell Biology

Anticancer effect of adenosine on gastric cancerviadiverse signaling pathways

(2015) Ayako Tsuchiya   WORLD JOURNAL OF GASTROENTEROLOGY

Adenosine Receptors: Expression, Function and Regulation

(2014) Sandeep Sheth et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Adenosine Regulates the Proinflammatory Signaling Function of Thrombin in Endothelial Cells

(2014) Seyed Mahdi Hassanian et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity

(2014) J. Bastid et al.   Cancer Immunology Research

Close correlation between MEK/ERK and Aurora-B signaling pathways in sustaining tumorigenic potential and radioresistance of gynecological cancer cell lines

(2013) FRANCESCO MARAMPON et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Adenosine receptors as drug targets — what are the challenges?

(2013) Jiang-Fan Chen et al.   NATURE REVIEWS DRUG DISCOVERY

Influence of the Serotonin Transporter 5HTTLPR Polymorphism on Symptom Severity in Irritable Bowel Syndrome

(2013) Rocchina Colucci et al.   PLoS One

CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer

(2013) S. Loi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Adenosine induces cell cycle arrest and apoptosis via cyclinD1/Cdk4 and Bcl-2/Bax pathways in human ovarian cancer cell line OVCAR-3

(2013) Saeid Shirali et al.   TUMOR BIOLOGY

A Genome-wide RNAi Screen Reveals a Trio-Regulated Rho GTPase Circuitry Transducing Mitogenic Signals Initiated by G Protein-Coupled Receptors

(2012) Jose P. Vaqué et al.   MOLECULAR CELL

Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer

(2012) Xiang Gao et al.   Nanoscale

Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go?

(2012) V. Kumar   Purinergic Signalling

Nucleoside transporters are widely expressed in ovarian carcinoma effusions

(2011) Annika J. Bock et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity

(2011) Sebastian F. M. Häusler et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Adenosine A2B Receptor Blockade Slows Growth of Bladder and Breast Tumors

(2011) C. Cekic et al.   JOURNAL OF IMMUNOLOGY

International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors--An Update

(2011) B. B. Fredholm et al.   PHARMACOLOGICAL REVIEWS

CD73 on Tumor Cells Impairs Antitumor T-Cell Responses: A Novel Mechanism of Tumor-Induced Immune Suppression

(2010) D. Jin et al.   CANCER RESEARCH

Adenosine receptors as drug targets

(2010) Bertil B. Fredholm   EXPERIMENTAL CELL RESEARCH

Adenosine receptors interacting proteins (ARIPs): Behind the biology of adenosine signaling

(2009) Francisco Ciruela et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Adenosine suppresses CW2 human colonic cancer growth by inducing apoptosis via A1 adenosine receptors

(2009) Masaru Saito et al.   CANCER LETTERS

Screening for Ovarian Cancer

(2009) Daniel L. Clarke-Pearson   NEW ENGLAND JOURNAL OF MEDICINE

A2B adenosine receptors in immunity and inflammation

(2009) György Haskó et al.   TRENDS IN IMMUNOLOGY

HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak

(2008) J. C. Morote-Garcia et al.   BLOOD

Central role of Sp1-regulated CD39 in hypoxia/ischemia protection

(2008) H. K. Eltzschig et al.   BLOOD

Adenosine receptors: therapeutic aspects for inflammatory and immune diseases

(2008) György Haskó et al.   NATURE REVIEWS DRUG DISCOVERY

Pharmacological modulation of adenosine system: Novel options for treatment of inflammatory bowel diseases

(2007) Luca Antonioli et al.   INFLAMMATORY BOWEL DISEASES

Adenosine in the central nervous system: release mechanisms and extracellular concentrations

(2003) Serena Latini et al.   JOURNAL OF NEUROCHEMISTRY